Singapore's NTU Researchers Lead Breakthrough in Understanding Bacterial Tactics in Wound Infections
Singapore's research landscape continues to shine with a groundbreaking discovery from Nanyang Technological University (NTU Singapore) scientists. Researchers from the Singapore-MIT Alliance for Research and Technology (SMART) Antimicrobial Resistance (AMR) group, in collaboration with the Singapore Centre for Environmental Life Sciences Engineering (SCELSE) at NTU, have revealed how the common bacterium Enterococcus faecalis (E. faecalis) manipulates the body's immune system to cause persistent wound infections.
This finding, detailed in a study published in Cell Host & Microbe, explains why some wounds, particularly chronic ones like diabetic foot ulcers and post-surgical sites, resist healing despite antibiotic treatment. The work highlights NTU's pivotal role in global health research, positioning Singapore as a hub for innovative biomedical solutions.
The Science Behind Stubborn Wounds: Enterococcus faecalis and Its Immune-Evading Strategy
Enterococcus faecalis, a gram-positive bacterium frequently found in hospital settings and the human gut, is notorious for its antibiotic resistance and role in nosocomial infections. In wounds, it doesn't just survive; it actively sabotages host defenses. The NTU-led team discovered that E. faecalis floods the wound site with lactic acid, drastically lowering the pH to around 6.0-6.5. This acidification disrupts macrophage function—these are the frontline immune cells responsible for detecting pathogens via pattern recognition receptors and initiating inflammation through cytokines like IL-6 and TNF-α.
Normally, macrophages activate the nuclear factor kappa B (NF-κB) pathway upon sensing bacterial components, triggering gene expression for antimicrobial responses. However, lactic acid from E. faecalis enters macrophages through the monocarboxylate transporter 1 (MCT-1), acidifying the intracellular environment and inhibiting extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) phosphorylation. This reduces MyD88 adaptor protein levels, crucial for Toll-like receptor signaling. Simultaneously, extracellular lactic acid binds the G protein-coupled receptor 81 (GPR81), promoting yes-associated protein (YAP) phosphorylation, further dampening NF-κB.
The dual mechanism—intracellular acidification via MCT-1 and receptor-mediated signaling via GPR81—effectively 'switches off' the immune alarm, allowing E. faecalis to persist and pave the way for polymicrobial infections with pathogens like Escherichia coli.
NTU Singapore's SMART and SCELSE: Hubs of Collaborative Excellence
The study exemplifies NTU Singapore's strength in interdisciplinary research. SMART, a flagship NTU-MIT partnership funded by Singapore's National Research Foundation (NRF) under the CREATE programme, focuses on tackling antimicrobial resistance—a global crisis. SCELSE, NTU's environmental life sciences center, provides expertise in microbial ecology. Lead researchers Dr. Ronni A.G. da Silva, a Research Scientist at SMART AMR and SCELSE-NTU Visiting Researcher, and Prof. Kimberly A. Kline, Principal Investigator at SMART AMR, SCELSE-NTU Visiting Academic, and Professor at the University of Geneva, spearheaded the effort. Collaborators from MIT's Koch Institute added molecular biology prowess.
Dr. da Silva noted, "Chronic wound infections often fail not because antibiotics are powerless, but because the immune system has effectively been ‘switched off’ at the infection site." Prof. Kline emphasized the potential for new wound care strategies targeting bacterial immunosuppression.
This collaboration underscores Singapore's investment in higher education research, with NTU consistently ranking among Asia's top universities for biological sciences.
The Burden of Chronic Wounds in Singapore: A Growing Public Health Challenge
In Singapore, chronic wounds impose a significant economic strain, costing an estimated S$350 million annually—0.07% of GDP—as of recent estimates. Diabetic foot ulcers (DFUs), a primary type, affect about 170 per 100,000 people, with diabetes prevalence at 12.5% and rising. By 2050, over one million Singaporeans may have diabetes, amplifying DFU risks due to neuropathy and poor circulation.
NTU's research is timely, as polymicrobial infections complicate 60% of DFUs globally, leading to longer hospital stays, amputations (up to 20% of severe cases), and high mortality (37.9% over five years in some cohorts). In Singapore's multi-ethnic population, arterial and venous ulcers add to the incidence, with age-adjusted rates doubling in recent decades.
Experimental Evidence from NTU Labs: Mouse Models Reveal the Mechanism Step-by-Step
The team employed sophisticated in vitro and in vivo models. In RAW 264.7 and bone marrow-derived macrophages (BMDMs), E. faecalis infection reduced NF-κB reporter activity by 70%, IL-6 production by 80%, and p65 nuclear translocation. Lactic acid dehydrogenase (LDH) mutants (Δldh1/Δldh2) failed to suppress, restoring immunity. Acidification with HCl mimicked effects, confirming pH role.
- Transporter inhibition (AZD3965 for MCT-1) or GPR81 knockout restored NF-κB by 60-90%.
- STAT3 agonists like ML115 enhanced bacterial killing 10-fold.
- In murine excisional wounds, wild-type E. faecalis persisted 7 days post-infection (dpi) at 10^5 CFUs, vs. mutants cleared by 3 dpi.
- Polymicrobial wounds: E. coli CFUs increased 100-fold with E. faecalis co-infection due to suppressed immunity.
These results, visualized in mouse wound biopsies showing reduced p65 and MyD88, provide robust evidence.
Polymicrobial Infections: How E. faecalis Paves the Way for Superinfections
Chronic wounds often harbor multiple species because E. faecalis creates an immunosuppressive niche. The study showed co-infection with E. coli—a gram-negative opportunist—led to E. coli overgrowth as macrophages failed to produce IL-12 and TNF-α. This mirrors clinical polymicrobial wounds (50-70% cases), where biofilms form, exacerbating resistance.
In Singapore hospitals, such infections prolong stays by 2-3x, increasing amputation risks in diabetics.
Therapeutic Horizons: Beyond Antibiotics to Immune Restoration
Traditional antibiotics target bacteria but ignore immune sabotage. NTU's insights suggest:
- pH-neutralizing dressings with catalase to degrade H2O2/peroxides.
- MCT-1/GPR81 inhibitors to block lactic acid signaling.
- STAT3 activators or NF-κB agonists to revive macrophages.
- Probiotics or lactate-free antimicrobials.
Preclinical trials are next, potentially revolutionizing wound care. Link to the full study for details: Cell Host & Microbe paper.
NTU Singapore's Role in Singapore's Biomedical Ecosystem
NTU, ranked #15 globally (QS 2026), invests heavily in life sciences. SCELSE and SMART exemplify public-private partnerships, with NRF funding >S$100m. This study boosts Singapore's reputation, attracting talent and funding. For aspiring researchers, NTU offers programs in microbiology and bioengineering.
Stakeholders like Singapore's Ministry of Health praise such work amid rising diabetes (projected 1m cases by 2050).
Challenges and Future Directions for Singapore Wound Research
While promising, translating to humans requires trials. Challenges: Wound heterogeneity, patient comorbidities. NTU plans human biopsies, advanced models. Broader implications for aging population, where chronic wounds rise 2x/decade.
Stakeholder Perspectives: From Clinicians to Policymakers
Singapore clinicians note 20% DFU recurrence; this could cut amputations 30%. Policymakers eye cost savings (S$350m/year). Quotes reinforce urgency.SMART press release.
Outlook: Transforming Wound Care Through Singapore Innovation
NTU's discovery heralds immune-centric therapies, reducing Singapore's wound burden. It inspires higher ed focus on translational research, benefiting global health.
